Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$4,330,221
+$386,693 QoQ
Shares Held
17,208
-5.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
#1,403
of 4,153 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Founders Financial Alliance, LLC holds $16,023,148 across 10 Drug Manufacturers - General names. ABBV ranks #1 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
17,208 | $4,330,221 | |
| 2 | JNJ |
Johnson & Johnson
|
16,743 | $4,252,219 | |
| 3 | LLY |
ELI LILLY & Co
|
1,993 | $2,390,464 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,983 | $2,053,815 | |
| 5 | AMGN |
Amgen Inc
|
2,252 | $815,494 | |
| 6 | PFE |
Pfizer Inc
|
33,547 | $807,811 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,222 | $531,371 | |
| 8 | AZN |
Astrazeneca PLC
|
1,540 | $292,014 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,330,221 | 17,208 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $3,943,528 | 18,132 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,212,213 | 18,435 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,247,601 | 18,345 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $3,401,486 | 18,325 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,834,635 | 18,302 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $3,203,931 | 18,030 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,846,910 | 19,480 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $3,395,752 | 19,798 | Shares | Sole | 2024-08-26 | |
| 2024-03-31 | $3,612,317 | 19,837 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,072,125 | 19,824 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,881,031 | 19,328 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,697,159 | 20,019 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,110,424 | 19,517 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,129,416 | 19,364 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,586,360 | 19,271 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,386,098 | 9,050 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,885,720 | 17,801 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,567,048 | 18,959 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,813,401 | 16,811 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,878,713 | 16,679 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,777,285 | 16,423 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,600,807 | 14,940 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $1,060,092 | 12,103 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||